As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Global antimalarial drugs market is expected to register double digit CAGR during the forecast period owing to increasing prevalence of malaria and COVID-19 around the world. According to various studies, tablets containing hydroxychloroquine have the ability to inhibit the virus that causes corona. This is acting as a major factor behind the exponential demand for antimalarial drugs across various nations. Moreover, the growing focus of governments towards the treatment of COVID-19 is also a key factor for growth of antimalarial drugs market. With increasing research and development activities to develop new antimalarial drugs, the market is poised to witness significant growth in the coming years.

Additionally, rise in malaria death cases, especially in developing nations are also fueling the growth of antimalarial drugs market. According to World Health Organization (WHO), about half of the world's population is at risk of malaria. Moreover, with increasing awareness initiative by governments, the global antimalarial drugs market is anticipated to witness rapid growth through 2025.

Global antimalarial drugs market can be segmented based on drug type, drug class, route of administration, malaria type, application, distribution channel and region. Based on drug class, the market can be segmented into aryl aminoalcohol compounds, antifolate compounds, artemisinin compounds and antimicrobials. Among them, the aryl aminoalcohol compounds segment is expected to witness high growth during the forecast period owing to rising cases of malaria across the world.

Based on route of administration, the global antimalarial drugs market can be segmented into oral, powder inhalation and intravenous administration. Among them, the oral segment is expected to undergo high growth through 2025 owing to the advantages such as safety, easy ingestion, pain avoidance and better patient compliance. Also, hydroxychloroquine comes only in tablet form, and hence, the segment is expected to witness significant growth in the coming years.

Major companies operating in global antimalarial drugs market include F. Hoffmann-La Roche Ltd, Alvizia Healthcare Pvt. Ltd., Bayer AG, Cipla Limited, GlaxoSmithKline Plc, Ipca Laboratories Ltd., Mayne Pharma Group Limited, Merck & Co., Inc, , King Pharmaceuticals, Inc, Novartis AG, Zydus Cadila, Sanofi S.A., Pfizer Inc., Sun Pharmaceutical Industries Ltd. (Ranbaxy Laboratories), Strides Pharma Science Limited, Glenmark Pharmaceuticals and Lincoln Pharmaceuticals, among others. The market players are adopting growth strategies like new product launches, mergers & partnerships to increase their global market share.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global antimalarial drugs market.
  • To forecast global antimalarial drugs market based on drug type, drug class, route of administration, malaria type, application, distribution channel, company and regional distribution.
  • To identify drivers and challenges for global antimalarial drugs market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions etc. in global antimalarial drugs market.
  • To identify and analyze the profile of leading players operating in the global antimalarial drugs market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of antimalarial drugs companies across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the companies which could not be identified due to the limitations of secondary research.

TechSci Research calculated global antimalarial drugs market size using a bottom-up approach, where data for various end user industries and its application across various product types were recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analysing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also used by TechSci Research.

Key Target Audience:

  • Antimalarial drugs manufacturers, companies/partners and other stakeholders
  • Hospital pharmacy/ retail pharmacy
  • Government bodies such as regulating authorities and policy makers
  • Organizations, industry associations, forums and alliances related to antimalarial drugs
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as antimalarial drugs manufacturers, end users etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global antimalarial drugs market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Antimalarial Drugs Market, By Drug Type:
    • Quinine
    • Chloroquine
    • Proguanil
    • Amodiaquine
    • Mefloquine
    • Hydroxychloroquine
    • Pyrimethamine
    • Others
  • Global Antimalarial Drugs Market, By Drug Class:
    • Aryl Aminoalcohol Compounds
    • Antifolate Compounds
    • Artemisinin Compounds
    • Antimicrobials
  • Global Antimalarial Drugs Market, By Route of Administration:
    • Oral
    • Powder Inhalation
    • Intravenous Administration
  • Global Antimalarial Drugs Market, By Malaria Type:
    • Plasmodium Falciparum
    • Plasmodium Malariae
    • Plasmodium Vivax
    • Plasmodium Ovale
    • Plasmodium Knowlesi
  • Global Antimalarial Drugs Market, By Application:
    • Prevention
    • Treatment of Malaria
  • Global Antimalarial Drugs Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • E-Commerce
    • Others
  • Global Antimalarial Drugs Market, By Region:
    • Asia-Pacific
      • China
      • Japan
      • India 
      • South Korea
      • Australia
      • Singapore
    • Europe
      • France
      • Germany
      • United Kingdom
      • Italy
      • Spain
    • North America
      • United States
      • Mexico
      • Canada
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global antimalarial drugs market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Profit Margin Analysis

  • Profit margin analysis in case of direct and indirect sales channel.
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Antimalarial Drugs Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Antimalarial Drugs Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Quinine, Chloroquine, Proguanil, Amodiaquine, Mefloquine, Hydroxychloroquine, Pyrimethamine, Others)

6.2.2.     By Drug Class (Aryl Aminoalcohol Compounds, Antifolate Compounds, Artemisinin Compounds, Antimicrobials)

6.2.3.     By Route of Administration (Oral, Powder Inhalation, Intravenous Administration)

6.2.4.     By Malaria Type (Plasmodium Falciparum, Plasmodium Malariae, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Knowlesi)

6.2.5.     By Application (Prevention, Treatment of Malaria)

6.2.6.     By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, E-Commerce, Others)

6.2.7.     By Company (2019)

6.2.8.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Antimalarial Drugs Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Drug Type

7.2.2.     By Drug Class

7.2.3.     By Route of Administration

7.2.4.     By Malaria Type

7.2.5.     By Application

7.2.6.     By Distribution Channel

7.2.7.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Antimalarial Drugs Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value & Volume

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Drug Type

7.3.1.2.2.             By Drug Class

7.3.1.2.3.             By Route of Administration

7.3.1.2.4.             By Malaria Type

7.3.1.2.5.             By Application

7.3.1.2.6.             By Distribution Channel

7.3.2.     India Antimalarial Drugs Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value & Volume

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Drug Type

7.3.2.2.2.             By Drug Class

7.3.2.2.3.             By Route of Administration

7.3.2.2.4.             By Malaria Type

7.3.2.2.5.             By Application

7.3.2.2.6.             By Distribution Channel

7.3.3.     Japan Antimalarial Drugs Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value & Volume

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Drug Type

7.3.3.2.2.             By Drug Class

7.3.3.2.3.             By Route of Administration

7.3.3.2.4.             By Malaria Type

7.3.3.2.5.             By Application

7.3.3.2.6.             By Distribution Channel

7.3.4.     South Korea Antimalarial Drugs Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value & Volume

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Drug Type

7.3.4.2.2.             By Drug Class

7.3.4.2.3.             By Route of Administration

7.3.4.2.4.             By Malaria Type

7.3.4.2.5.             By Application

7.3.4.2.6.             By Distribution Channel

7.3.5.     Singapore Antimalarial Drugs Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value & Volume

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Drug Type

7.3.5.2.2.             By Drug Class

7.3.5.2.3.             By Route of Administration

7.3.5.2.4.             By Malaria Type

7.3.5.2.5.             By Application

7.3.5.2.6.             By Distribution Channel

7.3.6.     Australia Antimalarial Drugs Market Outlook

7.3.6.1.         Market Size & Forecast

7.3.6.1.1.             By Value & Volume

7.3.6.2.         Market Share & Forecast

7.3.6.2.1.             By Drug Type

7.3.6.2.2.             By Drug Class

7.3.6.2.3.             By Route of Administration

7.3.6.2.4.             By Malaria Type

7.3.6.2.5.             By Application

7.3.6.2.6.             By Distribution Channel

8.    Europe Antimalarial Drugs Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Drug Type

8.2.2.     By Drug Class

8.2.3.     By Route of Administration

8.2.4.     By Malaria Type

8.2.5.     By Application

8.2.6.     By Distribution Channel

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Antimalarial Drugs Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value & Volume

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Drug Type

8.3.1.2.2.             By Drug Class

8.3.1.2.3.             By Route of Administration

8.3.1.2.4.             By Malaria Type

8.3.1.2.5.             By Application

8.3.1.2.6.             By Distribution Channel

8.3.2.     Germany Antimalarial Drugs Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value & Volume

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Drug Type

8.3.2.2.2.             By Drug Class

8.3.2.2.3.             By Route of Administration

8.3.2.2.4.             By Malaria Type

8.3.2.2.5.             By Application

8.3.2.2.6.             By Distribution Channel

8.3.3.     United Kingdom Antimalarial Drugs Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value & Volume

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Drug Type

8.3.3.2.2.             By Drug Class

8.3.3.2.3.             By Route of Administration

8.3.3.2.4.             By Malaria Type

8.3.3.2.5.             By Application

8.3.3.2.6.             By Distribution Channel

8.3.4.     Italy Antimalarial Drugs Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value & Volume